GRI
Income statement / Annual
Last year (2023), GRI Bio, Inc.'s total revenue was $21.77 M,
and the percentage change from the previous year is not available.
In 2023, GRI Bio, Inc.'s net income was -$13.04 M.
See GRI Bio, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
| Operating Revenue |
$21.77 M |
$0.00 |
$0.00 |
$100,000.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$57,000.00
|
$206,000.00
|
$73,000.00
|
$0.00
|
$735.00
|
$612.00
|
| Gross Profit |
$21.71 M
|
-$206,000.00
|
-$73,000.00
|
$100,000.00
|
-$735.00
|
-$612.00
|
| Gross Profit Ratio |
1
|
0
|
0
|
1
|
0
|
0
|
| Research and Development Expenses |
$3.23 M
|
$242,000.00
|
$249,000.00
|
$3.71 M
|
$1.88 M
|
$3.51 M
|
| General & Administrative Expenses |
$1.49 M
|
$2.00 M
|
$813,000.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$2.96 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$8.10 M
|
$2.00 M
|
$813,000.00
|
$1.11 M
|
$1.27 M
|
$800,076.00
|
| Other Expenses |
$102,000.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$11.33 M
|
$2.24 M
|
$1.06 M
|
$4.81 M
|
$3.15 M
|
$4.31 M
|
| Cost And Expenses |
$11.39 M
|
$2.24 M
|
$1.06 M
|
$4.89 M
|
$3.15 M
|
$4.31 M
|
| Interest Income |
$0.00
|
$26,000.00
|
$0.00
|
$0.00
|
$0.00
|
$1,061.00
|
| Interest Expense |
$2.08 M
|
$653,000.00
|
$547,000.00
|
$34,000.00
|
$197,026.00
|
$0.00
|
| Depreciation & Amortization |
$57,000.00
|
$50,000.00
|
$73,000.00
|
$75,000.00
|
$735.00
|
$612.00
|
| EBITDA |
-$10.90 M |
-$2.51 M |
-$9.21 M |
-$4.71 M |
-$3.27 M |
-$4.31 M |
| EBITDA Ratio |
-0.5
|
0
|
0
|
-47.13
|
0
|
0
|
| Operating Income Ratio |
-0.52
|
0
|
0
|
-47.88
|
0
|
0
|
| Total Other Income/Expenses Net |
-$1.65 M
|
-$978,000.00
|
-$8.24 M
|
-$34,000.00
|
-$310,072.00
|
$1,064.00
|
| Income Before Tax |
-$13.04 M
|
-$3.22 M
|
-$1.56 M
|
-$4.82 M
|
-$3.46 M
|
-$4.31 M
|
| Income Before Tax Ratio |
-0.6
|
0
|
0
|
-48.22
|
0
|
0
|
| Income Tax Expense |
$2.77 M
|
$325,000.00
|
-$50,000.00
|
-$131,297.00
|
$5.00
|
-$2.00
|
| Net Income |
-$13.04 M
|
-$3.54 M
|
-$1.51 M
|
-$4.82 M
|
-$3.46 M
|
-$4.31 M
|
| Net Income Ratio |
-0.6
|
0
|
0
|
-48.22
|
0
|
0
|
| EPS |
-28.25 |
-8.43 |
-4.65 |
-14.87 |
-10.68 |
-1728.57 |
| EPS Diluted |
-28.25 |
-8.43 |
-4.65 |
-14.87 |
-10.68 |
-1728.57 |
| Weighted Average Shares Out |
$461,566.00
|
$420,000.00
|
$324,420.00
|
$324,330.00
|
$324,330.00
|
$2,494.92
|
| Weighted Average Shares Out Diluted |
$461,566.00
|
$420,000.00
|
$324,420.00
|
$324,330.00
|
$324,330.00
|
$2,494.92
|
| Link |
|
|
|
|
|
|
